Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Zamzam, A. Abak, K. Bakarman, F. Al-Jassir, K. Khoshhal, Marwan Zamzami (2009)
Efficacy of aspiration and autogenous bone marrow injection in the treatment of simple bone cystsInternational Orthopaedics, 33
É. Mezey, K. Chandross, G. Harta, Richard Maki, S. Mckercher (2000)
Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow.Science, 290 5497
Lin Song, R. Tuan (2004)
Transdifferentiation potential of human mesenchymal stem cells derived from bone marrowThe FASEB Journal, 18
S. Sharma, N. Garg, A. Veliath, S. Subramanian, K. Srivastava (1992)
Percutaneous bone-marrow grafting of osteotomies and bony defects in rabbits.Acta orthopaedica Scandinavica, 63 2
P. Niemeyer, U. Krause, J. Fellenberg, P. Kasten, A. Seckinger, A. Ho, H. Simank (2004)
Evaluation of Mineralized Collagen and α-Tricalcium Phosphate as Scaffolds for Tissue Engineering of Bone Using Human Mesenchymal Stem CellsCells Tissues Organs, 177
P. Bianco, M. Riminucci, S. Gronthos, P. Robey (2001)
Bone Marrow Stromal Stem Cells: Nature, Biology, and Potential ApplicationsSTEM CELLS, 19
N. Ogura, M. Kawada, Wei-Jen Chang, Qi Zhang, S. Lee, T. Kondoh, Y. Abiko (2004)
Differentiation of the human mesenchymal stem cells derived from bone marrow and enhancement of cell attachment by fibronectin.Journal of oral science, 46 4
L. Nail, J. Stanovici, J. Fournier, M. Splingard, J. Doménech, P. Rosset (2014)
Percutaneous grafting with bone marrow autologous concentrate for open tibia fractures: analysis of forty three cases and literature reviewInternational Orthopaedics, 38
M. Jäger, E. Jelinek, K. Wess, A. Scharfstädt, M. Jacobson, S. Kevy, R. Krauspe (2009)
Bone marrow concentrate: a novel strategy for bone defect treatment.Current stem cell research & therapy, 4 1
D. Smiler, M. Soltan (2006)
Bone Marrow Aspiration: Technique, Grafts, and ReportsImplant Dentistry, 15
F. Barry, J. Murphy (2004)
Mesenchymal stem cells: clinical applications and biological characterization.The international journal of biochemistry & cell biology, 36 4
Barbara Bain (2005)
Bone marrow biopsy morbidity: review of 2003Journal of Clinical Pathology, 58
H. Sugaya, H. Mishima, K. Aoto, Meihua Li, Yukiyo Shimizu, T. Yoshioka, Shinsuke Sakai, H. Akaogi, N. Ochiai, M. Yamazaki (2014)
Percutaneous autologous concentrated bone marrow grafting in the treatment for nonunionEuropean Journal of Orthopaedic Surgery & Traumatology, 24
E. Lagasse, Heather Connors, M. Al‐Dhalimy, Michael Reitsma, M. Dohse, L. Osborne, Xin Wang, M. Finegold, I. Weissman, M. Grompe (2000)
Purified hematopoietic stem cells can differentiate into hepatocytes in vivoNature Medicine, 6
P. Hernigou, G. Mathieu, A. Poignard, O. Manicom, F. Beaujean, H. Rouard (2005)
Percutaneous Autologous Bone-Marrow Grafting for Nonunions
AbstractIntroduction: The titanium implant represents a foreign body for the organism in which it is inserted, and it will never be accepted as an intrinsic structure. However, research has shown that it is very well supported both by soft and hard tissues, including here the limitrophe implant tissues.Aim of the study: The aim of this study was to test the tolerability towards the titanium implant inserted in direct contact with the hematogenous marrow.Material and methods: Titanium implants with the length of 10 mm and the diameter of 2 mm were inserted in the diaphysis of the femora bone of 10 male rabbits with the age of 10 months. At these particular dimensions, the implant exceeded the depth of the bone wall with more than half its length, taking direct contact with the hematogenous marrow from the marrow channel.Results: Seven days after the implants insertion, the histologic examination revealed the fact that the hematogenous marrow had a very good lenience towards the titanium implant, meaning that it did not lead to any immunological rejection reactions, nor to pathological processes or the tendency of proliferation of unwanted tissues like conjunctive fibrous tissue. In these conditions, the pre-implantation reparatory processes fully benefited of the hematogenous marrow support, which, not being altered in any way, offered cells and stimulant factors, of the same intensity, throughout the entire experimental period. Conclusions: The high tolerance of the hematogenous marrow to the titanium implant assures special conditions for the peri-implantation reparatory processes which take place at a speed that cannot be competed against by other stimulant modalities. This stimulant modality of reparatory processes cannot be applied in all situations, but only when working on healthy bones that contain hematogenous marrow, therefore the practical applicability relates especially to the dental interventions of implant prosthesis.
Acta Stomatologica Marisiensis Journal – de Gruyter
Published: Dec 1, 2022
Keywords: hematogenous marrow; titanium implant; bone proliferation
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.